Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Bridget Griffiths.

Newcastle AuthorsTitleYearFull text
Dr Rebecca Batten
Dr Bridget Griffiths
BSR guideline on the management of adults with systemic lupus erythematosus (SLE) 2018: baseline multi-centre audit in the UK2021
Dr Bridget Griffiths
Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally2021
Dr Rebecca Batten
Dr Bridget Griffiths
Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus2021
Dr Bridget Griffiths
Anantha Madhavan
Deena Harji
A multicentre, prospective, observational cohort study of variation in practice in perioperative analgesia strategies in elective laparoscopic colorectal surgery (the LapCoGesic study)2020
Peter Coyne
Dr Bridget Griffiths
Richard Brady
Contemporary smartphone and social media resources for patients with anal cancer: an unmet need2020
Dr Lesley Kay
Dr Bridget Griffiths
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic2020
Deena Harji
Dr Bridget Griffiths
Laparoscopic versus open colorectal surgery in the acute setting (LaCeS trial): a multicentre randomized feasibility trial2020
Dr Jessica Tarn
Dr Nadia Howard-Tripp
Dr Dennis Lendrem
Andrew Skelton
Dr Katherine James
et al.
Symptom-based stratification of patients with primary Sjögren’s syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials2019
Professor John Allen
Dr Bridget Griffiths
Audrey Macdonald
A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography2018
Professor Fai Ng
Dr Katherine James
Dr Bridget Griffiths
Dr David Coady
Dr Steven Young-Min
et al.
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: Examination of data from the UK Primary Sjögren's Syndrome Registry2018
Dr Bridget Griffiths
Dr James Miller
Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: A 10-year epidemiological study2018
Professor John Allen
Costanzo Di Maria
Dr Sam Urwin
Dr Alan Murray
Dr Lesley Ottewell
et al.
Novel optical assessments of tissue composition and viability using fluorescence spectroscopy and tissue oxygenation spectrophotometry in patients with systemic sclerosis - a pilot study2018
Dr Bridget Griffiths
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register2018
Shereen Al-Ali
Dr Jessica Tarn
Dr Dennis Lendrem
Dr Bridget Griffiths
Professor Fai Ng
et al.
Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity2018
Dr Bridget Griffiths
Professor John Isaacs
The EuroMyositis registry: An international collaborative tool to facilitate myositis research2018
Dr James Locke
Dr Bridget Griffiths
Professor Fai Ng
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA2017
Sheryl Mitchell
Dr Katherine James
Professor Fai Ng
Dr Bridget Griffiths
Vicki Hindmarsh
et al.
Corrigendum: Eligibility for clinical trials in primary Sjögren's syndrome: Lessons from the UK Primary Sjögren's Syndrome Registry [Rheumatology, 55, (2016) (544-552)] doi:10.1093/rheumatology/kev3732017
Professor Fai Ng
Ariana Miller
Dr Steven Young Min
Dr David Coady
Dr Bridget Griffiths
et al.
Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome2017
Dr Bridget Griffiths
Professor John Allen
Quantification of differences between nailfold capillaroscopy images with a scleroderma pattern and normal pattern using measures of geometric and algorithmic complexity2017
Dr Peter Gallagher
Sheryl Mitchell
Dr Bridget Griffiths
Vicki Hindmarsh
Ben Hargreaves
et al.
Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren’s Syndrome – Capturing the discrepancy2017
Dr Bridget Griffiths
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence guidelines in England and Wales2017
Dr Nadia Howard-Tripp
Dr Jessica Tarn
Dr Colin Gillespie
Dr Dennis Lendrem
Dr Bridget Griffiths
et al.
A Cytokine-Mediated Biological Basis for Fatigue in Primary Sjögren’s Syndrome2016
Dr Bridget Griffiths
BSR and BHPR guideline for the treatment of systemic sclerosis2016
Dr Bridget Griffiths
Development of Evidence-Based Recommendations for Diagnosis, Assessment and Treatment of Lupus2016
Sheryl Mitchell
Dr Katherine James
Professor Fai Ng
Dr Bridget Griffiths
Vicki Hindmarsh
et al.
Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry2016
Dr Jessica Tarn
Andini Natasari
Colin Gillespie
Sheryl Mitchell
Dr Katie Hackett
et al.
Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines2016
Dr Bridget Griffiths
A Paper Patient-Based Flare Study in SLE2015
Dr Katherine James
Shereen Al-Ali
Dr Jessica Tarn
Dr Simon Cockell
Dr Colin Gillespie
et al.
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome2015
Ben Hargreaves
Dr Dennis Lendrem
Vicki Hindmarsh
Claire Humphrey
Sheryl Mitchell
et al.
Assignable Causes for Fatigue in Primary Sjögren’s Syndrome: Data from the UK Primary Sjögren’s Syndrome Registry2015
Dr Dennis Lendrem
Sheryl Mitchell
Dr Peter McMeekin
Dr Katie Hackett
Sarah Bowman
et al.
Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome?2015
Dr Prosenjit Dutta
Dr Bridget Griffiths
Dr Ian Forrest
Efficacy of pulsed cyclophosphamide and methyl-prednisolone therapy in patients with progressive interstitial lung disease2015
Professor Fai Ng
Dr Katherine James
Dr Bridget Griffiths
Dr James Andrews
Dr Vadivelu Saravanan
et al.
Eligibility for Clinical Trials in Primary Sjogren's Syndrome: Lessons from the UK Primary Sjogren's Registry2015
Shereen Al-Ali
Dr Simon Cockell
Dr Jessica Tarn
Dr Katherine James
Sarah Bowman
et al.
Identification of Whole Blood Gene Expression Signature in Primary Sjogren's Syndrome Associated Lymphoma2015
Dr Bridget Griffiths
Infections Observed in Rituximab Treated Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register2015
Dr Jessica Tarn
Dr Dennis Lendrem
Dr Colin Gillespie
Shereen Al-Ali
Dr Bridget Griffiths
et al.
Patient Sub-Phenotyping in Primary Sjogren's Syndrome2015
Dr Bridget Griffiths
Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multi-Centre Register2015
Professor Jaap van Laar
Dr Bridget Griffiths
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial2014
Sheryl Mitchell
Dr Bridget Griffiths
Professor Fai Ng
Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results2014
Dr Dennis Lendrem
Sheryl Mitchell
Dr Peter McMeekin
Dr Bridget Griffiths
Professor Fai Ng
et al.
Health-related utility values of patients with primary Sjögren's syndrome and its predictors2014
Shereen Al-Ali
Dr Simon Cockell
Andrew Skelton
Dr Katherine James
Dr Jessica Tarn
et al.
Identification of Whole Blood Gene Expression Signature in Primary Sjogren's Syndrome Associated Lymphoma2014
Dr Neil McKay
Dr Bridget Griffiths
Costanzo Di Maria
Stephen Hedley
Professor Alan Murray
et al.
Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: a pilot study2014
Dr Bridget Griffiths
Patients with Refractory Systemic Lupus Erythematosus Requiring Biologic Therapy Have Significant Levels of Baseline Co-Morbidities: Results from a National Multi-Centre Register2014
Dr Bridget Griffiths
Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register2014
Dr Jessica Tarn
Dr Simon Cockell
Dr Colin Gillespie
Shereen Al-Ali
Dr Katherine James
et al.
Whole Blood microRNA Signature for Primary Sjogren's Syndrome-Related Lymphoma2014
Dr Marzena Ciechomska
Dr Bridget Griffiths
Professor Sophie Hambleton
Professor Jaap van Laar
The Role of Serum Factors and Toll-Like Receptor Signaling in the Induction of Profibrotic TIMP-1 by Monocytes in Systemic Sclerosis2013
Nadine Binai
Dr Steven O'Reilly
Dr Bridget Griffiths
Professor Jaap Van Laar
Differentiation Potential of CD14(+) Monocytes into Myofibroblasts in Patients with Systemic Sclerosis2012
Dr Dennis Lendrem
Sheryl Mitchell
Sarah Bowman
Dr Bridget Griffiths
Heather Foggo
et al.
Evaluating health status of 620 patients with primary sjögren’s syndrome using EQ-5D2012
Dr Dennis Lendrem
Sheryl Mitchell
Sarah Bowman
Dr David Coady
Dr Bridget Griffiths
et al.
How good are the eular sjögren’s syndrome disease activity index, and eular sjögren’s syndrome patients reported index in predicting health status in primary sjögren’s syndrome?2012
Sheryl Mitchell
Dr Bridget Griffiths
Professor Fai Ng
Potential diagnostic utility of anti-centromere antibody in primary Sjogren's syndrome in the UK2012
Dr Steven O'Reilly
Dr Bridget Griffiths
Dr Anja Krippner-Heidenreich
Professor Jaap Van Laar
T cell derived IL-6 and IL-13 drive fibroblast fibrosis: Implications for systemic sclerosis2012
Sheryl Mitchell
Dr David Coady
Dr Bridget Griffiths
Dr Dennis Lendrem
Heather Foggo
et al.
The clinical relevance of anti-RO52 and anti-RO60 in patients in the united kingdom primary sjögren’s syndrome registry (UKPSSR)2012
Professor Julia Newton
Sheryl Mitchell
Dr Bridget Griffiths
Professor Fai Ng
Potentially treatable symptoms in primary Sjogren's Syndrome - Associated fatigue2011
Professor Fai Ng
Dr Bridget Griffiths
Professor Marco Carrozzo
United Kingdom Primary Sjogren's Syndrome Registry - a united effort to tackle an orphan rheumatic disease2011
Dr Thomas Huegle
Arie Huigens
Dr Lesley Ottewell
Dr Bridget Griffiths
Professor Jaap Van Laar
et al.
The role of fibrocytes in systemic sclerosis [Poster session]2009
Dr Graham Raftery
Dr Bridget Griffiths
Dr Lesley Kay
Dr David Kane
Chronic viral hepatitis and TNF-alpha blockade2007
Dr Bridget Griffiths
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon - A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril2007
Professor John Allen
Elizabeth Kokkinos
Professor Alan Murray
Emeritus Professor Brian Diffey
Dr Simon Meggitt
et al.
Assessment of skin fluorescence characteristics in systemic sclerosis2006
Dr Bridget Griffiths
Charlotte Gordon
BILAG-2004 index: A reliable tool for assessment of SLE activity2006
Charlotte Gordon
Dr Bridget Griffiths
Dr Asad Rahman
Preliminary Rasch analysis of SLEDAI-2000 index: An ordinal scale index with internal construct validity2006
Dr Bridget Griffiths
Revised British isles lupus assessment group 2004 index - A reliable tool for assessment of systemic lupus erythematosus activity2006
Professor Namita Kumar
Dr Bridget Griffiths
Professor John Allen
Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: A potential treatment2006
Dr Bridget Griffiths
Professor John Isaacs
Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study2005
Dr Bridget Griffiths
Professor John Isaacs
Analysis of Fcγ receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B2005
Dr Bridget Griffiths
Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices2005
Dr Asad Rahman
Dr Bridget Griffiths
Charlotte Gordon
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus2005
Dr Bridget Griffiths
Dr Asad Rahman
Charlotte Gordon
BILAG-2004 captures SLE disease activity better than SLEDAI-20002005
Dr Bridget Griffiths
Charlotte Gordon
BILAG-2004 index: A reliable tool for assessment of SLE activity2005
Dr Bridget Griffiths
Charlotte Gordon
Development and validation of a disease specific quality of life measure for adults with systemic lupus erythematosus, the LupusQoL2005
Professor John Allen
Karen Walker
Dr Bridget Griffiths
Professor Alan Murray
Skin temperature and objective colour measurements in patients with Raynaud’s phenomenon secondary to connective tissue disease2005
Dr Alice Lorenzi
Kathryn Walker
Dr Angela Patterson
Dr Bridget Griffiths
Professor John Isaacs
et al.
Thymic function is impaired in patients with a variety of autoimmune diseases2005
Dr Nitin Kumar
Professor John Allen
Professor Alan Murray
Dr Bridget Griffiths
A pilot study assessing the response of single dose sildenafil citrate (Viagra) in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis2004
Dr Huseyn Sahin
Dr Bridget Griffiths
Issues in cross-cultural validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford health assessment questionnaire2004
Dr Bridget Griffiths
Professor Namita Kumar
Professor Alan Murray
Subject preparation and thermal acclimatization prior to mild cold challenge testing using dynamic thermal imaging2003
Dr Bridget Griffiths
Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: Influence of reading with or without known sequence2002
Dr Bridget Griffiths
Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference2002
Dr Bridget Griffiths
Systemic sclerosis and interstitial lung disease: A pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function2002
Dr Bridget Griffiths
Professor John Isaacs
Fcγ receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups2000